Angiopoietins-1 and -2 are differentially expressed in the sera of patients with systemic sclerosis: high angiopoietin-2 levels are associated with greater severity and higher activity of the disease

Clinical Significance of Serum Levels of Vascular Endothelial Growth Factor, Angiopoietin-1, and Angiopoietin-2 in Patients with Rheumatoid Arthritis

(2010) D. KUROSAKA et al.   JOURNAL OF RHEUMATOLOGY

The transport of high amounts of vascular endothelial growth factor by blood platelets underlines their potential contribution in systemic sclerosis angiogenesis

(2009) A. Solanilla et al.   RHEUMATOLOGY

The Tie2 receptor antagonist angiopoietin 2 facilitates vascular inflammation in systemic lupus erythematosus

(2008) P Kumpers et al.   ANNALS OF THE RHEUMATIC DISEASES

Autoantibodies and microvascular damage are independent predictive factors for the progression of Raynaud's phenomenon to systemic sclerosis: A twenty-year prospective study of 586 patients, with validation of proposed criteria for early systemic sclerosis

(2008) Martial Koenig et al.   ARTHRITIS AND RHEUMATISM

Vascular Disease in Scleroderma: Mechanisms of Vascular Injury

(2008) Bashar Kahaleh   RHEUMATIC DISEASE CLINICS OF NORTH AMERICA

The Pathology of Scleroderma Vascular Disease

(2008) Jo Nadine Fleming et al.   RHEUMATIC DISEASE CLINICS OF NORTH AMERICA

The Immunobiology of Systemic Sclerosis

(2008) Y. Stephanie Gu et al.   SEMINARS IN ARTHRITIS AND RHEUMATISM